Breedalia SL

Breedalia SL is a Spanish company with a vision to revolutionize the production of medical cannabis in Valencia using innovative technologies. The company is set to acquire its cultivation license and GACP certificate by mid-2020, positioning itself to be a key player in the B2B distribution of medical cannabis in Spain. By harnessing Valencia's favorable weather conditions and implementing cutting-edge Industry 4.0 technologies for crop management, Breedalia SL aims to offer high-quality medical cannabis that complies with European regulations. Utilizing a 1,500m² greenhouse, Breedalia SL plans to begin production by mid-2021, targeting an annual yield of 750kg of cannabis flower. Notably, the company employs a dual lighting system that combines natural and artificial light to reduce expenses and operate in an eco-friendly manner, leveraging Valencia's 4500 hours of sunlight per year. In collaboration with a GMP-certified partner, Breedalia SL is committed to supplying customers with dried cannabis flowers and extracts adhering to the highest pharmaceutical standards. With Germany and Italy identified as primary markets, the company is currently open to equity investors seeking to participate in its initial stages. The innovative approach, focus on compliance and sustainability, and strategic market positioning make Breedalia SL a compelling opportunity for potential investors interested in the burgeoning medical cannabis industry.